184 related articles for article (PubMed ID: 12682273)
1. Human T cells express a functional ionotropic glutamate receptor GluR3, and glutamate by itself triggers integrin-mediated adhesion to laminin and fibronectin and chemotactic migration.
Ganor Y; Besser M; Ben-Zakay N; Unger T; Levite M
J Immunol; 2003 Apr; 170(8):4362-72. PubMed ID: 12682273
[TBL] [Abstract][Full Text] [Related]
2. TCR activation eliminates glutamate receptor GluR3 from the cell surface of normal human T cells, via an autocrine/paracrine granzyme B-mediated proteolytic cleavage.
Ganor Y; Teichberg VI; Levite M
J Immunol; 2007 Jan; 178(2):683-92. PubMed ID: 17202328
[TBL] [Abstract][Full Text] [Related]
3. Expression of ionotropic glutamate receptor GLUR3 and effects of glutamate on MBP- and MOG-specific lymphocyte activation and chemotactic migration in multiple sclerosis patients.
Sarchielli P; Di Filippo M; Candeliere A; Chiasserini D; Mattioni A; Tenaglia S; Bonucci M; Calabresi P
J Neuroimmunol; 2007 Aug; 188(1-2):146-58. PubMed ID: 17628700
[TBL] [Abstract][Full Text] [Related]
4. Human T-leukemia and T-lymphoma express glutamate receptor AMPA GluR3, and the neurotransmitter glutamate elevates the cancer-related matrix-metalloproteinases inducer CD147/EMMPRIN, MMP-9 secretion and engraftment of T-leukemia in vivo.
Ganor Y; Grinberg I; Reis A; Cooper I; Goldstein RS; Levite M
Leuk Lymphoma; 2009 Jun; 50(6):985-97. PubMed ID: 19391040
[TBL] [Abstract][Full Text] [Related]
5. Glutamate, T cells and multiple sclerosis.
Levite M
J Neural Transm (Vienna); 2017 Jul; 124(7):775-798. PubMed ID: 28236206
[TBL] [Abstract][Full Text] [Related]
6. Glutamate receptor antibodies in neurological diseases: anti-AMPA-GluR3 antibodies, anti-NMDA-NR1 antibodies, anti-NMDA-NR2A/B antibodies, anti-mGluR1 antibodies or anti-mGluR5 antibodies are present in subpopulations of patients with either: epilepsy, encephalitis, cerebellar ataxia, systemic lupus erythematosus (SLE) and neuropsychiatric SLE, Sjogren's syndrome, schizophrenia, mania or stroke. These autoimmune anti-glutamate receptor antibodies can bind neurons in few brain regions, activate glutamate receptors, decrease glutamate receptor's expression, impair glutamate-induced signaling and function, activate blood brain barrier endothelial cells, kill neurons, damage the brain, induce behavioral/psychiatric/cognitive abnormalities and ataxia in animal models, and can be removed or silenced in some patients by immunotherapy.
Levite M
J Neural Transm (Vienna); 2014 Aug; 121(8):1029-75. PubMed ID: 25081016
[TBL] [Abstract][Full Text] [Related]
7. Dual-Targeted Autoimmune Sword in Fatal Epilepsy: Patient's glutamate receptor AMPA GluR3B peptide autoimmune antibodies bind, induce Reactive Oxygen Species (ROS) in, and kill both human neural cells and T cells.
Levite M; Zelig D; Friedman A; Ilouz N; Eilam R; Bromberg Z; Ramadhan Lasu AA; Arbel-Alon S; Edvardson S; Tarshish M; Riek LP; Lako RL; Reubinoff B; Lebendiker M; Yaish D; Stavsky A; Galun E
J Autoimmun; 2020 Aug; 112():102462. PubMed ID: 32561150
[TBL] [Abstract][Full Text] [Related]
8. Glutamate stimulates oligodendrocyte progenitor migration mediated via an alphav integrin/myelin proteolipid protein complex.
Gudz TI; Komuro H; Macklin WB
J Neurosci; 2006 Mar; 26(9):2458-66. PubMed ID: 16510724
[TBL] [Abstract][Full Text] [Related]
9. Evidence that functional glutamate receptors are not expressed on rat or human cerebromicrovascular endothelial cells.
Morley P; Small DL; Murray CL; Mealing GA; Poulter MO; Durkin JP; Stanimirovic DB
J Cereb Blood Flow Metab; 1998 Apr; 18(4):396-406. PubMed ID: 9538905
[TBL] [Abstract][Full Text] [Related]
10. Properties of GluR3 receptors tagged with GFP at the amino or carboxyl terminus.
Limon A; Reyes-Ruiz JM; Eusebi F; Miledi R
Proc Natl Acad Sci U S A; 2007 Sep; 104(39):15526-30. PubMed ID: 17881566
[TBL] [Abstract][Full Text] [Related]
11. Expression of ionotropic glutamate receptor GLUR3 and effects of glutamate on MBP- and MOG-specific lymphocyte activation and chemotactic migration in multiple sclerosis patients.
Poulopoulou C; Hatzimanolis A
J Neuroimmunol; 2008 Feb; 194(1-2):191; author reply 192. PubMed ID: 17996951
[No Abstract] [Full Text] [Related]
12. Dominant negative mutant of ionotropic glutamate receptor subunit GluR3: implications for the role of a cysteine residue for its channel activity and pharmacological properties.
Watase K; Sekiguchi M; Matsui TA; Tagawa Y; Wada K
Biochem J; 1997 Mar; 322 ( Pt 2)(Pt 2):385-91. PubMed ID: 9065754
[TBL] [Abstract][Full Text] [Related]
13. AMPA receptor protein expression and function in astrocytes cultured from hippocampus.
Fan D; Grooms SY; Araneda RC; Johnson AB; Dobrenis K; Kessler JA; Zukin RS
J Neurosci Res; 1999 Aug; 57(4):557-71. PubMed ID: 10440906
[TBL] [Abstract][Full Text] [Related]
14. Lead-Induced ERK Activation Is Mediated by GluR2 Non-containing AMPA Receptor in Cortical Neurons.
Ishida K; Kotake Y; Sanoh S; Ohta S
Biol Pharm Bull; 2017; 40(3):303-309. PubMed ID: 28250271
[TBL] [Abstract][Full Text] [Related]
15. Glutamate mediates platelet activation through the AMPA receptor.
Morrell CN; Sun H; Ikeda M; Beique JC; Swaim AM; Mason E; Martin TV; Thompson LE; Gozen O; Ampagoomian D; Sprengel R; Rothstein J; Faraday N; Huganir R; Lowenstein CJ
J Exp Med; 2008 Mar; 205(3):575-84. PubMed ID: 18283118
[TBL] [Abstract][Full Text] [Related]
16. The neurotransmitter glutamate and human T cells: glutamate receptors and glutamate-induced direct and potent effects on normal human T cells, cancerous human leukemia and lymphoma T cells, and autoimmune human T cells.
Ganor Y; Levite M
J Neural Transm (Vienna); 2014 Aug; 121(8):983-1006. PubMed ID: 24584970
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological characterization of the human ionotropic glutamate receptor subtype GluR3 stably expressed in mammalian cells.
Varney MA; Rao SP; Jachec C; Deal C; Hess SD; Daggett LP; Lin F; Johnson EC; Veliçelebi G
J Pharmacol Exp Ther; 1998 Apr; 285(1):358-70. PubMed ID: 9536032
[TBL] [Abstract][Full Text] [Related]
18. Complex pharmacological properties of recombinant alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate receptor subtypes.
Stein E; Cox JA; Seeburg PH; Verdoorn TA
Mol Pharmacol; 1992 Nov; 42(5):864-71. PubMed ID: 1279377
[TBL] [Abstract][Full Text] [Related]
19. Stable expression of human homomeric and heteromeric AMPA receptor subunits in HEK293 cells.
Nishimura S; Iizuka M; Wakamori M; Akiba I; Imoto K; Barsoumian EL
Recept Channels; 2000; 7(2):139-50. PubMed ID: 10952090
[TBL] [Abstract][Full Text] [Related]
20. Glutamate receptor-mediated effects on growth and morphology of human histiocytic lymphoma cells.
Haas HS; Pfragner R; Siegl V; Ingolic E; Heintz E; Schauenstein K
Int J Oncol; 2005 Sep; 27(3):867-74. PubMed ID: 16077940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
